Home › Sjogren's Syndrome › California
Sjogren's Syndrome clinical trials in California
5 studies for Sjogren's Syndrome are looking for participants at sites in California.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Wallace Rheumatic Study Center, Beverly Hills
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Chula Vista, Chula Vista
- Artiva Investigational Site Covina, Covina
- Artiva Investigational Site Los Alamitos, Los Alamitos
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Samy Metyas MD Inc, Covina
- UCSD Altman Clinical and Translational Research Institute Building, La Jolla
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949The Myelin Disorders Biorepository Project
- Children's Hospital of Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- Stanford University (Lucile Packard Children's Hospital), Palo Alto
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.